The Food and Drug Administration is adding the sternest safety warnings available to prescription drugs used to cleanse the bowel before colonoscopies. The agency says it has received more than 20 reports of a rare but serious form of kidney failure among patients taking the drugs, known as oral phosphate products. The new boxed warning label will apply to Visicol and OsmoPrep ‘ both prescription tablets made by Salix Pharmaceuticals – and used for the purposes described above. The label warns that the drugs should be used with caution in older patients, those that suffer from dehydration and kidney disease or those that take medications that affect the kidneys.
The FDA is also concerned about the kidney risks from over-the-counter bowel cleansers, such as Fleet Phospho-soda, made by C.B. Fleet Company Inc. While many phosphate products sold without a prescription are only labeled to treat constipation, regulators said they are often used at higher doses to clear the colon. The FDA said in a statement:
The available data do not show a risk of acute kidney injury when these ‘over-the-counter’ products are used at the lower doses for laxative use. However, when used for bowel cleansing, these products have the same risks as prescription drugs.
The agency advised consumers not to use any of the over-the-counter products for bowel cleansing. While non-prescription products cannot receive boxed warnings, FDA officials plan to require stricter labeling on the dozens of over-the-counter phosphate drugs. The FDA first warned doctors and patients about potential kidney risks with the medications in 2006.
Source: Associated Press
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.